|
|
Volumn 12, Issue 8, 2012, Pages 508-509
|
|
Therapeutics: Antitumour potential of catalytic DNA
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD4 ANTIGEN;
CD8 ANTIGEN;
CELL CYCLE PROTEIN;
DEOXYRIBOZYME;
DNAZYME DZ13;
MATRIX METALLOPROTEINASE;
PROTEIN C JUN;
UNCLASSIFIED DRUG;
VASCULOTROPIN A;
ANGIOGENESIS;
ANTINEOPLASTIC ACTIVITY;
BASAL CELL CARCINOMA;
CANCER INHIBITION;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CELL MEMBRANE PERMEABILITY;
DOWN REGULATION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
HELPER CELL;
IN VIVO STUDY;
NONHUMAN;
NOTE;
ONCOGENE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SKIN CANCER;
SQUAMOUS CELL CARCINOMA;
|
|
EID: 84864376913
PISSN: 1474175X
EISSN: 14741768
Source Type: Journal
DOI: 10.1038/nrc3328 Document Type: Note |
|
Times cited : (3)
|
|
References (1)
|
